Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about OCUL

Recent news which mentions OCUL

Stocks That Hit 52-Week Lows On Friday
Tickers ACB AERI AGIO ALBO
Tags Benzinga MDT ACB
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers NRIX NRXP NTNX OCCI
Tags News YRD NRIX
From Benzinga
Expert Ratings for Ocular Therapeutix
Tickers OCUL
Tags OCUL Analyst Ratings Market News
From Benzinga
Earnings Scheduled For May 9, 2022
Tickers IFF III IIIV ITUB
Tags MGY VTRS TUSK
From Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags TSHA EXEL CRTX
From Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Tickers AGTC AMGN AMRN ATHX
Tags AGTC VRTX OCUP
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACON ALNA BLRX CABA
Tags Benzinga CABA BZI/TFM
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers HLBZ HNST HYFM HYRE
Tags MCRB SRNE ICLK
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers ACLX ADVM AFCG ALLK
Tags ORMP PRCH News
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Tickers ABT ANTX GSK IBB
Tags LYRA KLDO Biotech
From Benzinga
Recap: Ocular Therapeutix Q4 Earnings
Tickers OCUL
Tags Earnings Market News Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags TREX News NNI
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers LAWS LAZ LII LOVE
Tags OLMA VINC RDBX
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
Tickers OCUL
Tags News Biotech Health Care
From Benzinga
3 Small-Cap Stocks to Buy Now and Hold for the Long Haul
Tickers NNOX OCUL RNLX
Tags RNLX Market News NNOX
From Motley Fool
Expert Ratings For Ocular Therapeutix
Tickers OCUL
Tags Analyst Ratings OCUL Benzinga
From Benzinga
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
Tickers OCUL
Tags Health Care News Briefs
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ABSI ACAD ASRT CMPS
Tags OCUL ORIC SDC
From Benzinga
Ocular Therapeutix: Q3 Earnings Insights
Tickers OCUL
Tags Market News Earnings Benzinga
From Benzinga
Earnings Scheduled For November 8, 2021
Tickers GPMT GTES GWRS HIL
Tags HIL TGS TRIP
From Benzinga
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
Tickers OCUL
Tags BZI/AAR Benzinga Market News
From Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
Tickers AVIR BBIG GRTX MTCR
Tags OCUL News BBIG
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers BAC BJRI CCL MSFT
Tags Pre/Market Outlook Small Cap Benzinga
From Benzinga
55 Biggest Movers From Friday
Tickers AGEN ALTM AUPH BBIG
Tags IT Consulting & Other Services MSB AUPH
From Benzinga
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Tickers AGEN AVIR BMY DWAC
Tags MRK Market News BMY
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop
Tickers AXP CRTD DWAC MTCR
Tags PHUN Mid/Afternoon Market Update Intraday Update
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Tickers AGEN ARAY BFRA BPTS
Tags Intraday Update NURO EAR
From Benzinga
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
Tickers AXP CRTD DWAC MTCR
Tags Commodities Global Benzinga
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
Tickers AGEN ALTM ATHA BBIG
Tags BBIG ALTM GROM
From Benzinga
Here's Why Ocular Therapeutix Stock Is Sinking Today
Tickers OCUL
Tags Market News OCUL
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.